Published in J Inflamm (Lond) on May 30, 2013
Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis. J Am Soc Nephrol (2014) 1.03
Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo. Mol Cancer (2014) 0.92
High and low molecular weight hyaluronic acid differentially influence macrophage activation. ACS Biomater Sci Eng (2015) 0.86
Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors. Cancer Immunol Res (2015) 0.84
Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia. ACS Nano (2015) 0.84
Hyaluronan fragments as mediators of inflammation in allergic pulmonary disease. Immunobiology (2014) 0.80
Stimulation of TLR4 by LMW-HA induces metastasis in human papillary thyroid carcinoma through CXCR7. Clin Dev Immunol (2013) 0.80
IRF3 is an important molecule in the UII/UT system and mediates immune inflammatory injury in acute liver failure. Oncotarget (2016) 0.77
Effect of Melilotus extract on lung injury via the upregulation of tumor necrosis factor-α-induced protein-8-like 2 in septic mice. Mol Med Rep (2014) 0.76
Esophageal Squamous Cell Carcinoma Cells Modulate Chemokine Expression and Hyaluronan Synthesis in Fibroblasts. J Biol Chem (2015) 0.75
Chemically modified N-acylated hyaluronan fragments modulate proinflammatory cytokine production by stimulated human macrophages. J Biol Chem (2014) 0.75
Thrombin Cleavage of Inter-α-inhibitor Heavy Chain 1 Regulates Leukocyte Binding to an Inflammatory Hyaluronan Matrix. J Biol Chem (2016) 0.75
IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature (2005) 13.23
CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol (2001) 9.19
Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med (2005) 8.49
Interferons and their actions. Annu Rev Biochem (1987) 8.36
IRF family of transcription factors as regulators of host defense. Annu Rev Immunol (2001) 8.18
Type I interferons in host defense. Immunity (2006) 7.32
Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med (2002) 5.70
TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat Immunol (2002) 4.63
Resolution of lung inflammation by CD44. Science (2002) 4.09
Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol (2006) 3.32
Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol (2009) 3.17
Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest (2009) 2.96
Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest (1996) 2.86
The structure and function of hyaluronan: An overview. Immunol Cell Biol (1996) 1.84
MH-S, a murine alveolar macrophage cell line: morphological, cytochemical, and functional characteristics. J Leukoc Biol (1989) 1.78
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. Allergy (2009) 1.62
Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med (1995) 1.62
Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J Immunol (1997) 1.61
Hyaluronan mediates ozone-induced airway hyperresponsiveness in mice. J Biol Chem (2009) 1.55
The role of type I interferons in non-viral infections. Immunol Rev (2004) 1.50
Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells. J Immunol (2007) 1.38
A role for hyaluronan in macrophage accumulation and collagen deposition after bleomycin-induced lung injury. Am J Respir Cell Mol Biol (2000) 1.35
Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. Curr Drug Targets Cardiovasc Haematol Disord (2005) 1.30
Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-gamma in mouse macrophages. J Immunol (1998) 1.24
Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages. J Immunol (1999) 1.24
Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection. PLoS Pathog (2010) 1.22
A novel IFN regulatory factor 3-dependent pathway activated by trypanosomes triggers IFN-beta in macrophages and fibroblasts. J Immunol (2008) 1.18
ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors. Proc Natl Acad Sci U S A (2011) 1.17
Targeting TLR2 attenuates pulmonary inflammation and fibrosis by reversion of suppressive immune microenvironment. J Immunol (2009) 1.15
Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9. J Immunol (2010) 1.13
Mechanical stretch induces epithelial-mesenchymal transition in alveolar epithelia via hyaluronan activation of innate immunity. J Biol Chem (2011) 1.12
Interferon-gamma. Curr Opin Immunol (1992) 1.10
Differential regulation of hyaluronan-induced IL-8 and IP-10 in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol (2006) 0.96
Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages. Am J Physiol Lung Cell Mol Physiol (2000) 0.95
TLR4 is a negative regulator in noninfectious lung inflammation. J Immunol (2010) 0.90
Systemic responses during local viral infections: type I IFNs sound the alarm. Curr Opin Immunol (2011) 0.88
CpG-ODN inhibits airway inflammation at effector phase through down-regulation of antigen-specific Th2-cell migration into lung. Int Immunol (2007) 0.87
TLR4 through IFN-β promotes low molecular mass hyaluronan-induced neutrophil apoptosis. J Immunol (2010) 0.86
High-molecular-weight hyaluronic acids inhibit chemotaxis and phagocytosis but not lysosomal enzyme release induced by receptor-mediated stimulations in guinea pig phagocytes. Microbiol Immunol (1994) 0.84
Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma. Int J Cancer (2012) 0.82
Toll like receptor 2 mediates bleomycin-induced acute lung injury, inflammation and fibrosis in mice. Yao Xue Xue Bao (2010) 0.81
CpG oligodeoxynucleotides directly induce CXCR3 chemokines in human B cells. Biochem Biophys Res Commun (2004) 0.79
[The expression and role of Toll receptor 4 in renal tubular epithelial cells in hepatitis B virus infection]. Zhonghua Nei Ke Za Zhi (2011) 0.77
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant (2008) 7.10
The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity (2009) 6.86
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol (2011) 5.22
Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med (2009) 4.59
Role of LAG-3 in regulatory T cells. Immunity (2004) 4.36
Egr-2 and Egr-3 are negative regulators of T cell activation. Nat Immunol (2005) 3.74
Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol (2006) 3.32
Regulation of immune responses by mTOR. Annu Rev Immunol (2011) 3.08
A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood (2007) 2.69
A role for mammalian target of rapamycin in regulating T cell activation versus anergy. J Immunol (2007) 2.53
Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome. Biol Blood Marrow Transplant (2010) 2.17
Anergic T cells are metabolically anergic. J Immunol (2009) 2.12
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease. Blood (2010) 1.99
Determinants of conformational dimerization of Mad2 and its inhibition by p31comet. EMBO J (2006) 1.89
Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation. Proc Natl Acad Sci U S A (2011) 1.86
mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunol Rev (2012) 1.74
The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. Immunity (2010) 1.64
A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity. Immunity (2011) 1.58
Identification of DNA methyltransferase 3a as a T cell receptor-induced regulator of Th1 and Th2 differentiation. J Immunol (2009) 1.45
Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay. Clin Chem (2006) 1.45
A clinician's guide to the diagnosis and treatment of interstitial lung diseases. South Med J (2007) 1.43
mTOR: taking cues from the immune microenvironment. Immunology (2009) 1.38
Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3. Eur J Immunol (2008) 1.35
mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation. J Clin Invest (2015) 1.18
Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor. Cancer Immunol Immunother (2011) 1.16
Ascertainment of collagen vascular disease in patients presenting with interstitial lung disease. Respir Med (2009) 1.15
Role of mutation in Pseudomonas aeruginosa biofilm development. PLoS One (2009) 1.11
Retracted Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways. Nat Immunol (2013) 1.09
Sleep quality and health-related quality of life in idiopathic pulmonary fibrosis. Chest (2008) 1.09
Threat matrix: low-molecular-weight hyaluronan (HA) as a danger signal. Immunol Res (2005) 1.09
Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells. J Immunol (2012) 1.08
The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance induction. J Immunol (2004) 1.08
Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors. Cancer Cell (2003) 1.08
Advanced visualization of airways with 64-MDCT: 3D mapping and virtual bronchoscopy. AJR Am J Roentgenol (2007) 1.07
Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma. Pulm Med (2011) 1.00
Enhanced interaction between Hsp90 and raptor regulates mTOR signaling upon T cell activation. Mol Immunol (2009) 0.98
Cutting Edge: TCR-induced NAB2 enhances T cell function by coactivating IL-2 transcription. J Immunol (2006) 0.98
IL-21 dependent IgE production in human and mouse in vitro culture systems is cell density and cell division dependent and is augmented by IL-10. Cell Immunol (2006) 0.96
Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced. Drugs (2014) 0.96
Anti-oxidant inhibition of hyaluronan fragment-induced inflammatory gene expression. J Inflamm (Lond) (2008) 0.96
Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse. Blood (2007) 0.96
PI3K/mTOR signaling regulates prostatic branching morphogenesis. Dev Biol (2011) 0.96
Differential regulation of hyaluronan-induced IL-8 and IP-10 in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol (2006) 0.96
The adenosine a2a receptor inhibits matrix-induced inflammation in a novel fashion. Am J Respir Cell Mol Biol (2008) 0.95
De novo DNA methylation is required to restrict T helper lineage plasticity. J Biol Chem (2012) 0.94
Severe pulmonary hypertension in idiopathic nonspecific interstitial pneumonia. Pulm Circ (2012) 0.94
Pulmonary vaccination as a novel treatment for lung fibrosis. PLoS One (2012) 0.91
All PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and independent signaling pathways in T cells. Front Immunol (2012) 0.91
CD23 trimers are preassociated on the cell surface even in the absence of its ligand, IgE. J Immunol (2004) 0.91
Sprouty-2 regulates HIV-specific T cell polyfunctionality. J Clin Invest (2014) 0.90
Insight into the role of mTOR and metabolism in T cells reveals new potential approaches to preventing graft rejection. Curr Opin Organ Transplant (2014) 0.89
In vivo murine CD23 destabilization enhances CD23 shedding and IgE synthesis. Cell Immunol (2007) 0.89
Validation of the Cough Quality-of-Life Questionnaire in patients with idiopathic pulmonary fibrosis. Chest (2013) 0.89
Sensing the immune microenvironment to coordinate T cell metabolism, differentiation & function. Semin Immunol (2013) 0.87
Necessity of the stalk region for immunoglobulin E interaction with CD23. Immunology (2002) 0.86
Adenosine and anergy. Autoimmunity (2007) 0.86
Cell biology: the more MAD, the merrier. Nature (2005) 0.86
Source of biomass cooking fuel determines pulmonary response to household air pollution. Am J Respir Cell Mol Biol (2014) 0.84
Temperature effect on IgE binding to CD23 versus Fc epsilon RI. J Immunol (2003) 0.83
Hyaluronan fragments promote inflammation by down-regulating the anti-inflammatory A2a receptor. Am J Respir Cell Mol Biol (2011) 0.83
NF-kappa B activation mediates the cross-talk between extracellular matrix and interferon-gamma (IFN-gamma) leading to enhanced monokine induced by IFN-gamma (MIG) expression in macrophages. J Biol Chem (2002) 0.82
Identification of the molecular mechanism by which TLR ligation and IFN-gamma synergize to induce MIG. Clin Dev Immunol (2004) 0.82
Quieting T cells with Slfn2. Nat Immunol (2010) 0.81
Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis. BMC Pulm Med (2014) 0.81
An Fc domain protein-small molecule conjugate as an enhanced immunomodulator. J Am Chem Soc (2014) 0.80
Genetic and biochemical regulation of CD4 T cell effector differentiation: insights from examination of T cell clonal anergy. Immunol Res (2010) 0.80
Exploring functional in vivo consequences of the selective genetic ablation of mTOR signaling in T helper lymphocytes. Methods Mol Biol (2012) 0.79
A unique proteolytic fragment of alpha1-antitrypsin is elevated in ductal fluid of breast cancer patient. Breast Cancer Res Treat (2009) 0.79
Regulation of CD4⁺ and CD8⁺ effector responses by Sprouty-1. PLoS One (2012) 0.78
Slc7a5 helps T cells get with the program. Nat Immunol (2013) 0.77
Selective activation of antigen-experienced T cells by anti-CD3 constrained on nanoparticles. J Immunol (2013) 0.77
Targeted immunosuppression: no longer naïve. Clin Immunol (2011) 0.75
Respiratory CSI: diagnosing occupationally related lung disease. South Med J (2008) 0.75
Author reply: To PMID 22986377. Ann Intern Med (2013) 0.75
Correction: Immunological Priming Requires Regulatory T Cells and IL-10-Producing Macrophages To Accelerate Resolution from Severe Lung Inflammation. J Immunol (2016) 0.75